Cargando…
Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
Breast cancer (BC) is the most common female cancer and the second cause of death among women worldwide. The 5-year relative survival rate recently improved up to 90% due to increased population coverage and women’s attendance to organised mammography screening as well as to advances in therapies, e...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519022/ https://www.ncbi.nlm.nih.gov/pubmed/32975658 http://dx.doi.org/10.1186/s13244-020-00905-3 |